Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 1 ( January-March, 2016 ) > List of Articles

RESEARCH ARTICLE

Blood Pressure, Troponin, and Cardiovascular Function

Vijay Nambi, Jennifer B Cowart, Addison A Taylor, Jeffrey T Bates

Keywords : Biomarkers,Blood pressure,Cardiovascular disease,Coronary artery disease,Heart failure,High-sensitivity troponin,Hypertension,Prevention,Risk factors

Citation Information : Nambi V, Cowart JB, Taylor AA, Bates JT. Blood Pressure, Troponin, and Cardiovascular Function. Hypertens J 2016; 2 (1):21-27.

DOI: 10.5005/jp-journals-10043-0025

Published Online: 00-03-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Cowart JB, Taylor AA, Bates JT, Nambi V. Blood Pressure, Troponin, and Cardiovascular Function. Hypertens J 2016;2(1):21-27.


PDF Share
  1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 Oct 15;62(16):e147–e239.
  2. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 Apr 29;362(17):1575-1585.
  3. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015 Nov 26;373(22):2103-2116.
  4. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003 May 21;289(19):2560-2572.
  5. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013 July;31(7):1281-1357.
  6. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 Feb 5;311(5):507-520.
  7. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 Dec 14;360(9349): 1903-1913.
  8. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail 2009 Dec;11(12):1129-1134.
  9. Prehypertension: is it relevant for nephrologists? Kidney Int 2010 Feb;77(3):194-200.
  10. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 Jul 1;63(25 Pt B):2935–2959.
  11. Clinical significance of endothelial dysfunction in essential hypertension. Curr Hypertens Rep 2015 Nov;17(11):85.
  12. Pulse pressure, arterial stiffness, and end-organ damage. Curr Hypertens Rep 2012 Aug;14(4):339-344.
  13. Myocardial remodeling in hypertension. J Hum Hypertens 2015 Jan;29(1):1-6.
  14. The progression from hypertension to congestive heart failure. JAMA 1996 May 22-29;275(20):1557-1562.
  15. Prehypertension is associated with abnormalities of cardiac structure and function in the Atherosclerosis Risk in Communities Study. Am J Hypertens 2015 Sep 7.
  16. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967 Dec 11202(11):1028-1034.
  17. A cooperative study. JAMA 1977 Jan 17;237(3):255-261.
  18. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014 Aug 16;384(9943):591-598.
  19. Should we adjust blood pressure treatment based on cardiovascular risk? Copyright 2015, American College of Cardiology Foundation. Available at: http://www.acc.org/latest-in-cardiology/articles/2015/03/06/09/45/should-we-adjust-blood-pressure-treatment-based-on-cardiovascular-risk. Accessed December 9, 2015.
  20. Human cardiac troponin complex. Structure and functions. Biochemistry (Mosc) 2013 Dec;78(13):1447-1465.
  21. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014 Dec 23;64(24):e139–e228.
  22. How to interpret elevated cardiac troponin levels. Circulation 2011 Nov 22;124(1):2350-2354.
  23. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury and non-elevated troponins. Am J Med 2015 Dec 1 [Epub ahead of print].
  24. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006 Apr 25;113(16): 1958-1965.
  25. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012 Sep;33(18):2252-2257.
  26. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007 Sep 11;116(11):1242-1249.
  27. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013 Mar 26;61(12):1240-1249.
  28. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010 Dec 8;304(22):2503-2512.
  29. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011 Apr 5;123(13):1367-1376.
  30. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010 Dec 8;304(22):2494-2502.
  31. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol 2013 Jan 15;61(2):187-195.
  32. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension 2015 Jan;65(1):78-84.
  33. The progression of hypertensive heart disease. Circulation 2011 Jan 25;123(3):327-334.
  34. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J 1991 Apr;121 (4 Pt 1):1244-1263.
  35. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med 1996 Sep 9;156(16):1789-1796.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.